Compound 506 (2-amino-6-methoxypurine arabinoside) is active against resistant T-cell malignancies: Preliminary results of a Phase I trial prior to definition of a MTD.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Kurtzberg, J; Wiley, J; Reese, M; Elion, G; Mitchell, B

Published Date

  • November 15, 1995

Published In

Volume / Issue

  • 86 / 10

Start / End Page

  • 2034 - 2034

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Language

  • English